Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 80.40

-1.4%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (4647)	5/6/2011 7:27:06 PM
From: bob zagorin	of 4676

thanks.. mipo filing info from cc.. from the transcript "...Most significant events of this year should be the mipomersen filings for marketing approval in Europe and U.S. Not only it is an important event for Genzyme and us, plus important for sanofi. In fact sanofi highlighted mipomersen regulatory filings as important upcoming milestones in both their earnings press release and their conference call last week. We are obviously very pleased with the progress the teams have made and now can confidently tell you that European filing will be in July. In the US, our initial filing is also on track to be filled in the second half of this year. Some of the most exciting progress that has been made recently is the evolution of Genzyme’s plans for commercialization of mipomersen...."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next